Triphenylphosphine → (+/-)-4-{1-[3,5-Difluoro-4-(4-trifluoromethyl-pyrazol-1-yl)-phenoxy]-butyl}-benzoic acid ethyl ester

HRID 1520970Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1520970
[F:1][C:2]1[CH:3]=[C:4]([OH:18])[CH:5]=[C:6]([F:17])[C:7]=1[N:8]1[CH:12]=[C:11]([C:13]([F:16])([F:15])[F:14])[CH:10]=[N:9]1.O[CH:20]([C:24]1[CH:34]=[CH:33][C:27]([C:28]([O:30][CH2:31][CH3:32])=[O:29])=[CH:26][CH:25]=1)[CH2:21][CH2:22][CH3:23].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.N(C(OCCC=[N+]=[N-])=O)=NC([O-])=O>O1CCCC1>[CH2:31]([O:30][C:28](=[O:29])[C:27]1[CH:33]=[CH:34][C:24]([CH:20]([O:18][C:4]2[CH:5]=[C:6]([F:17])[C:7]([N:8]3[CH:12]=[C:11]([C:13]([F:15])([F:16])[F:14])[CH:10]=[N:9]3)=[C:2]([F:1])[CH:3]=2)[CH2:21][CH2:22][CH3:23])=[CH:25][CH:26]=1)[CH3:32]

Komponenten

6

Versuchsvorschrift

3,5-Difluoro-4-(4-trifluoromethyl-pyrazol-1-yl)-phenol (230 mg, 0.871 mmol) was combined with ethyl 4-(1-hydroxybutyl)benzoate (see Intermediate 5) (194 mg, 0.871 mmol) and dissolved in anhydrous tetrahydrofuran (4 mL). Triphenylphosphine (457 mg, 1.74 mmol) was added followed by diazopropyl azodicarboxylate (0.451 mL, 2.18 mmol). This was stirred at room temperature as a yellow solution. At 17 h, the reaction was concentrated. Purification by silica gel flash chromatography (ethyl acetate in heptane) gave impure (+/−)-4-{1-[3,5-difluoro-4-(4-trifluoromethyl-pyrazol-1-yl)-phenoxy]-butyl}-benzoic acid ethyl ester (0.411 g) as a clear oil. 1H NMR (400 MHz, CDCl3, δ): 8.06 (d, J=8.2 Hz, 2H) 7.93 (s, 1H) 7.82 (s, 1H) 7.39 (d, J=8.4 Hz, 2H) 6.54 (d, J=9.4 Hz, 2H) 5.15 (dd, J=7.6, 5.3 Hz, 1H) 4.39 (q, J=7.2 Hz, 2H) 1.96-2.10 (m, 1H) 1.77-1.91 (m, 1H) 1.19-1.61 (m, 5H) 0.98 (t, J=7.3 Hz, 3H); MS (M+1): 469.3.

Aufarbeitung

  1. concentrationthe reaction was concentrated
  2. customPurification by silica gel flash chromatography (ethyl acetate in heptane)

Quellen und Nachweise

ORD-Eintrag
ord-cd72e70f76184dcaa15d975231600386
Quelldatensatz
uspto-grants-2015_07
Patentnummer
US09073871B2

Notizen zur Reaktion

Wird geladen…